Determination of Verapamil and Norverapamil in Serum by High-Performance Liquid Chromatography
- 31 March 1983
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 6 (5) , 887-893
- https://doi.org/10.1080/01483918308067010
Abstract
A simple, rapid, sensitive and specific high-performance liquid chromatographic method is developed for the determination of verapamil and its active metabolite norverapamil in human serum. The sample (100 μl) is vortex-mixed with methanol (200 μl) and after centrifugation 100 μl of the supernatent is used for the analysis of a C8 reverse-phase column (10 cm × 5 mm) with methanol - 0.1 M ammonium acetate (55:45 v/v) as the mobile phase. The compounds are detected fluorimetrically with a detection limit of 5 μ/l using an excitation wavelength of 278 nm and an emission wavelength of 320 nm. The method is applicable to pharmacokinetic studies and to therapeutic monitoring of the drug and its active metabolite.This publication has 6 references indexed in Scilit:
- Rapid high-performance liquid chromatographic method for the measurement of verapamil and norverapamil in blood plasma or serumJournal of Chromatography A, 1981
- High-performance liquid chromatographic determination of verapamil in plasma by fluorescence detectionJournal of Pharmaceutical Sciences, 1981
- Simultaneous determination of verapamil and its seven metabolites by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- GLC Assay of Verapamil in Plasma: Identification of Fluorescent Metabolites after Oral Drug AdministrationJournal of Pharmaceutical Sciences, 1979
- Fluorometric Assay of Verapamil in Biological Fluids and TissuesJournal of Pharmaceutical Sciences, 1976